Home » Pharmacology » 7-TM Receptors » Peptide Receptors » VIP Receptors » VIP (human, rat, mouse, rabbit, canine, porcine)

VIP (human, rat, mouse, rabbit, canine, porcine)

Cat. No. 1911

Price and Availability

For VIP (human, rat, mouse, rabbit, canine, porcine) pricing & availability please select your country from the drop down menu:
Submit

By clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy.

Alternative Name: Vasoactive Intestinal Peptide (human, rat, mouse, rabbit, canine, porcine)

Biological Activity

Neuropeptide with many biological actions; plays a role in neurotransmission, smooth muscle relaxation and has trophic and mitogenic actions.

Technical Data

M.Wt:

3325.83

Formula:

C₁₄₇H₂₃₈N₄₄O₄₂S

Sequence:

HSDAVFTDNYTRLRKQMAVKKYLNSILN

(Modifications: Asn-28 = C-terminal amide)

Solubility:

Soluble to 1 mg/ml in water

Storage:

Desiccate at -20°C

CAS No:

40077-57-4

The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.

Resources

Certificate of Analysis / Safety Data Sheet

Certificate of Analysis: View current batch

Select another batch:

Safety Data Sheet: View Safety Data Sheet

References

Harmar et al (1998) International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol.Rev. 50 265. PMID: 9647867.

Laburthe and Couvineau (2002) Molecular pharmacology and structure of VPAC receptors for VIP and PACAP. Regul.Pept. 108 165. PMID: 12220741.

If you know of a relevant citation for this product please let us know.

View Related Products by Target

Peptide Receptors

VIP Receptors

Keywords: VIP (human, rat, mouse, rabbit, canine, porcine), supplier, Involved, neurotransmission, smooth, muscle, relaxation, Vasoactive, Intestinal, Peptide, Receptors, VPAC, VIP, agonists

Quick Order

Find multiple products by catalog number

7-TM Receptor Signaling

Written by T. Kenakin et al

'Seven Transmembrane Receptor Signaling' highlights the multiple behaviors of 7-TMs including G-protein-dependent and -independent signaling as well as the concept of collateral efficacy

New Therapies and Challenges in Asthma

Written by Peter J. Barnes

'New Therapies, Challenges, and Breakthroughs in Asthma' highlights key pathways and new therapies used to treat asthma, including those currently in clinical development.